Current Employee4.0Aug 24, 2023biggest challenge is the unrealistic targets but biggest takeaway is OTJ learnings
Current Employee3.0May 29, 2025This rating is for an aesthetic account manager. Extremely lucrative until 2023 when company had IPO, CEO runs co as like a big Pharma company which it is NOT. No Work/Life balance, while you're not on call you are available to your customers 24/7 basically and there is LOTS of busy work that cuts into field time. Single Distributor is very difficult to work with and...Read More
This rating is for an aesthetic account manager. Extremely lucrative until 2023 when company had IPO, CEO runs co as like a big Pharma company which it is NOT. No Work/Life balance, while you're not on call you are available to your customers 24/7 basically and there is LOTS of busy work that cuts into field time. Single Distributor is very difficult to work with and...Read More
Current Employee1.9Mar 4, 2025Quotas are unattainable and leadership really isn’t interested in acknowledging the downturn of the industry
Quotas are unattainable and leadership really isn’t interested in acknowledging the downturn of the industry
Current Employee2.1Jul 2, 2025(Aesthetics) — This company was in its prime in 2018-2022. Since they’ve gone public, everything is about budget and reps have been stripped of their resources & compensation. The industry itself is in a lull with an anti-filler movement and although pipeline seems decent, it may not be enough to overcome the direction of the company seeking profitability. The...Read More
(Aesthetics) — This company was in its prime in 2018-2022. Since they’ve gone public, everything is about budget and reps have been stripped of their resources & compensation. The industry itself is in a lull with an anti-filler movement and although pipeline seems decent, it may not be enough to overcome the direction of the company seeking profitability. The...Read More
